ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NUTX vs AHG // EV/EBITDA & P/E VALUATION

Nutex Health Inc. (NASDAQ) VS. Akso Health Group ADS (NASDAQ) • 15-METRIC TALLY: NUTX 7 — AHG 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NUTX VS. AHG) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NUTX AHG SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 50.80% -0.10% +50.90 NUTX /gross-margins <GO>
Return on Invested Capital (ROIC) 85.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 4.6x — — TIE /valuation <GO>
Free Cash Flow Yield 17.07% -1.12% +18.19 NUTX /fcf-yield <GO>
Operating Margin 31.50% -60.00% +91.50 NUTX /operating-margins <GO>
Net Profit Margin 8.10% -60.00% +68.10 NUTX /net-margins <GO>
Revenue Growth (YoY) 82.40% -6.40% +88.80 NUTX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.75 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 9/9 2/9 +7.00 NUTX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.7 53.8 -7.08 AHG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 17.1x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.44B $1.14B $299.3M NUTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NUTX REV AHG REV NUTX GROSS % AHG GROSS % NUTX FCF AHG FCF
FY 2025 $875.3M $13.8M 50.8% -0.1% $245.6M -$12.8M
FY 2024 $479.9M $14.8M 40.9% -1.9% $20.8M $1.0M
FY 2023 $247.6M $2.4M — — $1.3M $1.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NUTX // BETA —
AHG // BETA —